Recent studies using several teleost models have revealed that androgens increase the size of previtellogenic (primary and/or early secondary) ovarian follicles. To explore our hypothesis that androgens drive the development of primary follicles into early secondary follicles, and to determine the mechanisms underlying these androgenic effects, we exposed juvenile coho salmon to nearphysiological and relatively sustained levels of the nonaromatizable androgen 11-ketotestosterone (11-KT). This resulted in significant growth of primary ovarian follicles after 10 and 20 days, with follicles after 20 days displaying a morphological phenotype characteristic of early secondary follicles (presence of cortical alveoli). Utilizing the same experimental approach, we then analyzed how 11-KT rapidly altered the ovarian transcriptome after 1 and 3 days of treatment. RNA-Seq analysis revealed that 69 (day 1) and 1,022 (day 3) contiguous sequences (contigs) were differentially expressed relative to controls. The differentially expressed contigs mapped to genes including those encoding proteins involved in gonadotropin, steroid hormone, and growth factor signaling, and in cell and ovarian development, including genes with putative androgen-response elements. Biological functions and canonical pathways identified as potentially altered by 11-KT include those involved in ovarian development, tissue differentiation and remodeling, and lipid metabolism. We conclude that androgens play a major role in stimulating primary ovarian follicle development and the transition into secondary growth.
Introduction
In oviparous vertebrates, the previtellogenic primary growth stage of oocyte development is characterized by intense synthesis of maternal RNAs, proteins, and lipids that are used to both facilitate maturation and fertilization, and to support early development of the zygote before zygotic genes begin to be expressed [1] [2] [3] . Growth of the primary oocyte is accompanied by the proliferation and functional differentiation of the surrounding somatic cell layers that together with the oocyte form the ovarian follicle. All components of the ovarian follicle participate in sending and receiving hormonal signals that coordinate ovarian follicle development (reviewed by Hsueh et al. [4] ).
Primary growth of ovarian follicles of teleost fish encompasses the chromatin nucleolus and perinucleolar stages, the former being a relatively transitory stage in many species. Perinucleolar follicles early in development are characterized by the presence of Balbiani bodies. These structures (or "nuages") are a dense mass of mitochondria, endoplasmic reticulum, germinal granules, germplasm RNAs, and RNA-binding proteins. In the late perinucleolar (LPN) stage, the Balbiani body disassembles and transcripts become associated with the vegetal pole of the follicle (review by Lubzens et al. [3] ). Completion of primary ovarian follicle development is often marked by the appearance of a few cortical alveoli (equivalent to the cortical granules of other species). Previtellogenic secondary follicle growth is characterized by the often massive accumulation of cortical alveoli, accompanied or followed by deposition of neutral and/or basic lipids, after which gonadotropin-mediated vitellogenesis commences [5] [6] [7] [8] [9] .
The genes encoding the beta polypeptides subunits of the pituitary gonadotropin (GTHs), follicle stimulating hormone (Fsh) and luteinizing hormone (Lh), are differentially expressed during secondary ovarian follicle development in teleosts [10] [11] [12] and the roles of the gonadotropins in regulating vitellogenesis and maturation of ovarian follicles are reasonably well-established. Plasma levels of Fsh increase during development of secondary ovarian follicles of teleosts, and this GTH stimulates follicular steroidogenesis, resulting in increased estradiol 17β (E2) production. E2 stimulates the synthesis of hepatic vitellogenin [5] , which is then incorporated into the ooplasm by a receptor-mediated process. In most species, Lh levels remain low throughout primary and secondary growth, but increase just prior to final oocyte maturation and ovulation [13] . Numerous experimental studies in a variety of teleost models confirm that the major actions of Lh are to stimulate follicular production of maturation-inducing progestins and prostaglandins, resulting in maturation of the oocyte and ovulation [5, 6] .
The endocrine regulation of primary growth of ovarian follicles and their transition into previtellogenic secondary follicle development is relatively less well understood. Early work showing that ovarian follicles of several hypophysectomized teleost species completed primary growth [14, 15] led to the concept that development of the primary follicle was "gonadotropin-independent" [16] . This idea has been challenged by recent zebrafish studies in which primary ovarian follicle growth was retarded in the absence of the follicle stimulating hormone-beta subunit [17] , and completely was arrested at the very early perinucleolar stage in the absence of the follicle stimulating hormone receptor (fshr) [18] . These phenotypes differ from those in mouse models, in which knockout studies suggest that local regulators largely drive early follicle development, with Fsh playing a facilitatory role [19] .
Irrespective of the precise roles of gonadotropins, studies on several species of teleosts indicate that androgens participate in promoting primary and/or early secondary ovarian follicle growth, depending on the model used. Androgens have been implicated in regulating development of an analogous stage, the preantral follicle, in mammals [20] [21] [22] [23] . Some of the earliest teleost studies used freshwater eels (Anguilla spp.) as a model. Anguillid eels undergo a significant physiological change prior to their seaward spawning migration, known as silvering. This change coincides with the transition to secondary growth and vitellogenesis in the ovary, and with remarkably high plasma concentrations of the teleost-specific nonaromatizable androgen, 11-ketotestosterone (11-KT) [24] . Androgen-induced ovarian follicle development and accumulation of lipids arrested at the completion of primary growth, in vivo [25] and in vitro [26] , respectively; E2 was without effect in vitro. Subsequent studies on eels showed that 11-KT stimulates cellular mechanisms that lead to lipid uptake and the accumulation of oil droplets in the ooplasm, resulting in a previtellogenic secondary follicle phenotype [9, [26] [27] [28] [29] . In cod with ovaries containing a mixture of follicles at various stages of primary development, androgens stimulated primary ovarian follicle development in vivo and in vitro [30, 31] , but only at pharmacological concentrations in vitro.
More recently, we have developed an in vitro model that exploits the advantages of using ovarian explants of coho salmon, Oncorhynchus kisutch [32] . Unlike many other teleosts species whose ovaries contain two and often more distinct clutches of ovarian follicles at different stages of development, coho salmon are semelparous, and females produce only a single clutch of oocytes before death. Because the coho salmon ovary displays highly synchronous ovarian follicle development with only a single class of follicles present at any time, histological analyses and interpretation of gene expression data are not confounded by the presence of multiple stages of primary and secondary follicles. We have demonstrated stagespecific effects of steroids on development of previtellogenic coho salmon follicles. At low concentrations in vitro, 11-KT promoted growth and development of mid-LPN follicles. At this stage, E2 had no growth-promoting effects. Conversely, the early cortical alveolus stage follicle was highly sensitive to E2. Both E2 and 11-KT at low concentrations caused marked increases in size of previtellogenic secondary oocytes (early cortical alveolus stage follicles), but E2 had a more substantial effect on the abundance of cortical alveoli [32] . Based on these in vitro data, we hypothesized that in coho salmon, androgens are the primary steroids driving the development of primary ovarian follicles through the transition into the early secondary growth stage, a stage in which E2 promotes both growth and synthesis of the stage-characteristic cortical alveoli.
This study was designed to provide further understanding of the role of androgens in regulating primary ovarian follicle development. We developed an in vivo coho salmon model using sustainedrelease 11-KT implants that demonstrated that this steroid promotes perinucleolar stage follicle development, which after 20 days of exposure, resulted in an early cortical alveolus stage phenotype similar to that seen in the in vitro studies described above. To reveal the molecular events that precede androgen-induced morphological changes, we used transcriptome sequencing to show that short-term in vivo treatment with 11-KT alters the expression of hundreds of genes associated with hormonal signaling pathways, steroidogenesis, tissue remodeling, lipid metabolism, and ovarian growth and development. 
Animals and tissue and blood sampling
All fish were maintained and treated following an approved protocol (4078-02) according to guidelines established by the Institutional Animal Care and Use Committee, University of Washington. For both studies described below, juvenile coho salmon (Issaquah Hatchery stock, Issaquah, WA) were reared from eyed embryos to 22-23 months of age at the hatchery facilities of the Northwest Fisheries Science Center, Seattle, WA, under simulated natural photoperiod in recirculated 10-11
• C fresh water. Fish were fed twice daily with a commercial feed, BioDiet (Bio-Oregon, Longview, WA) according to the manufacturer's guidelines. Either mixed sex fish or an all-female stock was used. Since gender cannot be determined by body morphology at this age in coho salmon, fish were implanted with passive-integrated transponder tags, and genetic sex was determined from DNA extracted from a small piece of fin tissue using a validated genetic marker for males [33] . At the termination of experiments, fish were anesthetized in buffered 0.05% tricaine methanesulfonate until movement of the gill operculum ceased. Fork length and body weight were measured. Blood was collected from the caudal vein using 21-gauge needles and heparinized 1 ml syringes and immediately transferred to microcentrifuge tubes and placed on ice. Blood plasma was separated by centrifugation at 1200 × g for 15 min. Fish were euthanized by decapitation and tissues were removed and weighed, and then either snap frozen in liquid nitrogen, or fixed in Bouin fixative for histological analysis. Gonadosomatic index (GSI) was calculated (ovary weight/bodyweight × 100).
Sex steroid assays
Steroids were double extracted from 250 μl of plasma using diethyl ether (1.5 ml × 2). Extracts were evaporated under nitrogen gas, and resuspended in assay buffer. Plasma 11-KT levels were measured by enzyme-linked immunoassay [34] using tracer and secondary antibody coated plates from Cayman Chemicals (Ann Arbor, MI) and primary antibody donated by David Kime (University of Sheffield, UK). Plasma E2 was measured by radioimmunoassay, as described by Sower and Schreck [35] , and modified by Fitzpatrick et al. [36] . Validation and characteristics of these assays have been reported previously [34, 35, 37] .
Histological analysis
Fixed tissues were washed with 70% ethanol, dehydrated in increasing concentrations of ethanol and xylene, and embedded in paraffin wax. Sections of 5 μm thickness were cut and mounted on microscope slides and stained with hematoxylin and eosin. Average ovarian follicle volume was calculated from at least 15 follicles per sample that were sectioned through the nucleus of the oocyte, using an image analysis system (NIS-elements, Nikon, USA), as described previously [32] . Oocytes were scored for stage based on previously published criteria [32, 38] .
Experimental procedures
Effects of long-term treatment with 11-ketotestosterone on perinucleolar stage follicle morphology and steroid levels The goal of this study was to determine if exposure to 11-KT in vivo resulted in promotion of ovarian follicle development similar to that reported for in vitro exposure [32] . At a time when females displayed mid-LPN stage ovarian follicles, coho salmon (mixed sex, 22-23 months old, approximately 77 g body weight) received peritoneal implants of either vehicle or vehicle containing 11-KT. Implants consisted of 1 μl/g body weight molten vegetable oil/vegetable shortening mixture with or without 2.5 mg/ml 11-KT, as described previously [39, 40] . Examination of the release characteristics in vitro showed a sustained rate of release of 11-KT for the first 12 days followed by a gradual decline thereafter [41] . Immediately prior to implantation, or after 10 or 20 days of exposure, fish were euthanized, and blood was collected. Upon dissection, males were discarded and ovaries from the first five females sampled in both control and 11-KT-treated groups were dissected out and fragments were fixed and processed for histological analyses. Ovarian follicle volume was determined as described above and data from controls and 11-KT-treated fish on day 10 and day 20 were compared using Students t-tests. Morphological characteristics of the oocytes were also recorded (e.g. appearance, cortical alveoli, loss of Balbiani bodies).
Alterations in the ovarian transcriptome after short-term 11-ketotestosterone treatment The goal of this study was to characterize the changes in the ovarian transcriptome that are initiated by 11-KT prior to pronounced morphological changes in the follicle. Female juvenile coho salmon, in the LPN stage of ovarian development (86.5 ± 4.8 g, 22-23 months of age), were implanted with either blank cholesterol pellets or pellets containing 11-KT. Preliminary studies demonstrated that this delivery system had similar release characteristics to the lipid-based delivery system described above, but with less individual variability in plasma levels of 11-KT attained. Cylindrical pellets (approximately 2 × 6 mm) of 30 mg [27, 42, 43] , with or without 5 μg 11-KT, were produced using a custom-made pellet press, and implanted into the peritoneal cavity (n = 10 females/treatment) using a 10-gauge needle and implanting syringe. Preliminary studies showed that pellets initially released high levels of 11-KT within the first 24 h, and then, as in the first experiment, a fairly constant rate of release through day 7. To temper the initial release of 11-KT, pellets were incubated for 24 h in sterile L-15 media (Thermo Fisher Scientific) and were then washed with L-15 prior to implantation. Fish were lethally sampled immediately prior to implantation or at 1 and 3 days after implantation. Fork length, body weight, and gonad weight were measured, and blood and ovaries were collected. After histological screening, any female with overtly asynchronous ovarian stages or with ovaries that were not at the mid-LPN stage were eliminated from further analyses. Frozen ovarian samples from three control and three implanted females at day 1 and day 3 were selected from remaining samples for RNA-Seq analysis. Plasma levels of 11-KT and E2 were also measured in female samples 7 days after implantation in order to compare with levels achieved in the first study.
RNA extraction
Total RNA was extracted using Qiagen RNEasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
RNA pellets were resuspended in DNAse/RNAse free water (SigmaAldrich). Total RNA concentrations in extracts were determined using a NanoDrop ND-100 (NanoDrop Technologies, Wilmington, DE). 
RNA-

RNA-Seq analysis
Bioinformatics procedures were performed according to a method modified from Harding et al. [44] . Sequences were quality trimmed using Trim Galore v0.4.0 [45] . Trimmed reads were assembled into a de novo backbone with Drap v1.8 [46] and Oases v0.2.09 [47] using the kmer values of 19, 23, 25, 27, 31, and 35. There were 60 838 contiguous sequences (contigs) that had FPKM (fragments per kilobase of transcript per million mapped reads) greater than 1 and had sequence lengths greater than 200 bp. The contigs were annotated using BlastX against the NCBI nonredundant protein database (nr) and partially nonredundant nucleotide database (nt); only sequences with an E-value ≤ 1E-05 were retained. Gene level count estimates were made using RSEM v.1.2.31 [48] and bowtie2 v2.2.6 [49] , and differential expression was determined using DESeq2 [50] . Contigs with a P-adjusted (P-adj) value ≤0.1 were considered significantly altered between control and 11-KT treatment. To control for sequencing errors and differences in sequencing depth leading to misidentification of differential expression of contigs with low read counts, basemean ≤10 were excluded from further analysis. Gene clustering at 1 and 3 days was performed using cluster::agnes package in R with the Spearman method [51] ; data were log 2 transformed and centered on a mean expression value to improve visualization of expression differences.
Pathway analysis
Ingenuity Systems Pathway Analysis (IPA) software (Qiagen) was used to conduct pathway and network analyses and estimate upstream and downstream effects of 11-KT treatment. Contigs were initially mapped to zebrafish orthologs using BLASTN against the Ensembl Danio rerio gene database (v.Zv9.72). However, some zebrafish genes have not been mapped to mammalian orthologs, so the remaining contigs were mapped to the Homo sapiens transcript database (v.GRCH37.72) for inclusion in IPA. If more than one contig (P ≤ 0.05) mapped to the same gene, the average expression value of those contigs was used as the gene expression value in further analyses. Zebrafish and human orthologs were compared to the Ingenuity Knowledge database to estimate altered canonical pathways and biological functions (Fisher exact test P ≤ 0.05 [-log 10 P-value ≥ 1.3]). This program generates networks that maximize the connectivity of genes with significantly altered expression based on known functional interactions [52] , predicts alterations in biological function, and predicts both upstream and downstream regulators given the direction of expression differences in given gene sets. A positive or negative z-score value indicates that a function is predicted to be increased or decreased in 11-KT-treated samples relative to controls. Zebrafish nomenclature is used throughout, although for the use of this software, human gene names are used in places where annotation to the zebrafish database was not possible.
Quantitative PCR assays
Genes related to steroidogenesis and ovarian function, as well as several differentially expressed genes (DEGs) identified from RNA-Seq analysis, were selected for quantitative PCR (qPCR) and compared with RNA-Seq expression data. Some of the genes were selected because their expression has been shown to be differentially regulated between LPN and midcortical alveolus stage follicles [53] Table S1 ) designed with Primer3plus software [56] using contigs derived from transcriptome sequencing, or from previously published primer sequences [37, 53] , were purchased from Integrated DNA Technologies (Coralville, IA).
Total volume for qPCR was 25 μl, and consisted of 12.5 μl Power SYBR Green Master Mix (ABI/Invitrogen, Foster City, CA), 150 nM of gene-specific forward and reverse primers, and 0.2 ng cDNA template based on total RNA loaded into the RT reaction. Assays were run on an ABI 7500 Sequence Detector in 96-well plates using standard cycling conditions: 50
• C for 2 min, 95
• C for 10 min, followed by 40 cycles consisting of 95
• C for 15 sec, and 60
• C for 1 min. A standard curve constructed from five concentrations of serially diluted cDNA synthesized from pooled ovary RNA (ranging from 0.004 to 4 ng) was included in each assay. No cDNA template controls (NTC) and no amplification controls (NAC, reverse transcriptase excluded from RT reaction) were included in each assay and showed no amplification over 40 cycles of PCR. Melt curve analyses showed single signals for all genes and no peaks were observed in NTC or NAC wells. Data were expressed relative to the expression of eukaryotic elongation factor 1 alpha (eef1a), which we have validated previously for use as a normalizer for coho salmon ovarian tissue [53] and which was stably expressed across treatments according to RNA-Seq analysis. The mean expression level of each gene transcript was compared between control and 11-KT samples at each time point using Student unpaired t-test with significance accepted at P < 0.05. Data were log 2 transformed to meet parametric test criteria. Mean transcript expression determined by qPCR was plotted against expression values determined by RNA-Seq and data were analyzed using Spearman correlation coefficient.
Results
Effects of long-term treatment with 11-ketotestosterone on perinucleolar stage follicle morphology and steroid levels
The mean ovarian follicle volume in 11-KT-implanted fish was 31% (P < 0.001) and 56% (P < 0.001) higher than that of controls at day 10 and day 20, respectively ( Figure 1A ). After 20 days of 11-KT treatment, approximately half of the ovarian follicles of 11-KT-treated fish displayed a few cortical alveoli, which were absent in controls and not observed in samples from females treated with 11-KT at day 10 ( Figure 1B-E) . Sex steroid levels were altered by 11-KT implants at both 10 and 20 days. Implants increased plasma 11-KT ( Figure 1F ) significantly from 0.03-0.09 ng/ml to 1.0 ng/ml Effects of short-term treatment of females with 11-KT for 1 and 3 days on plasma sex steroid levels. Plasma 11-KT (A) and E2 (B) levels (mean ± SEM) were significantly higher in females treated with 11-KT for 1 day (D1) and 3 days (D3) compared to control levels (
(10 days; P < 0.05) and to 0.3 ng/ml (20 days; P < 0.05). Levels of plasma 11-KT (0.03 ± 0.01 ng/ml) or E2 (0.12 ± 0.02 ng/ml) in fish collected immediately prior to implantation were not significantly different from controls at day 10. Plasma E2 levels ( Figure  1G ) in 11-KT-implanted fish (6.4 ng/ml) were 13-fold higher than controls (0.05 ng/ml) at day 20 (P < 0.0001). Levels of plasma 11-KT in controls decreased (P < 0.05) from 0.09 ng/ml on day 10 to 0.03 ng/ml on day 20 ( Figure 1F ).
Alterations in the ovarian transcriptome after short-term 11-ketotestosterone treatment Morphometrics and sex steroid levels Fork length, body weight, GSI, and ovarian follicle volume did not differ significantly between control and treated females at either day 1 or day 3 (all P > 0.8). Plasma levels of 11-KT ( Figure 2A ) in control fish at day 1 (0.04 ± 0.01 ng/ml) and day 3 (0.09 ± 0.05 ng/ml) were significantly lower than those in 11-KT-treated fish at day 1 (15.5 ± 5.6 ng/ml; P < 0.001) and day 3 (7.0 ± 2.1 ng/ml; P < 0.001). At day 7, 11-KT levels in controls (0.06 ± 0.003 ng/ml) were significantly lower (P < 0.01) than those in 11-KT-implanted females (3.56 ± 0.68 ng/ml). Plasma 11-KT (0.08 ± 0.13 ng/ml) and E2 (0.11 ± 0.00 ng/ml) levels in fish collected prior to implanting were not significantly different from control levels. Plasma E2 levels ( Figure 2B ) in 11-KT-implanted fish (0.15 ng/ml) were 2.2-fold higher than controls (0.07 ng/ml) at day 1 (P < 0.05) and 2.4-fold higher (0.14 ng/ml) than controls (0.06 ng/ml) at day 3 (P < 0.05). At day 7, although mean plasma E2 levels in 11-KT-treated fish (0.412 ± 0.32 ng/ml) were three to four times those of controls (0.128 ± 0.03 ng/ml), the difference was not significant. There were no observable morphological differences between follicles sampled from control and 11-KT-treated females, and histologically, these follicles were indistinguishable from the control follicles in the longterm exposure study, illustrated in Figure 1B and C.
RNA-Seq and bioinformatics
Sequencing using the Illumina HiSeq platform resulted in 1,611,376,806 total reads (805,688,403 matched paired end reads). Quality trimming resulted in 100% retained. Using these reads, de novo assembly generated 113,160 transcripts that were collapsed into 60,838 gene-cluster contigs of between 201 and 12,999 bases in length, with a mean of 1,207 bases. A total of 52,005 contigs were annotated and used in the creation of the backbone. Summary statistics for each sample can be found in Supplementary Table S2. A total of 69 contigs (30 upregulated and 39 downregulated) at day 1 and 1,022 contigs (680 upregulated and 342 downregulated) at day 3 were identified as differentially expressed between control and 11-KT treatment by RNA-Seq analysis (DESeq2, P-adj ≤ 0.1). Cluster analysis demonstrated consistent differences between control and treatment groups at both time points and considerable homogeneity among each of the three samples from control and 11-KT-treated fish at day 1 ( Figure 3A ) and day 3 ( Figure 3B ).
Contigs were annotated to zebrafish and human orthologs and uploaded into IPA to determine the biological processes potentially regulated by 11-KT in the ovary. A total of 33,899 (65%) out of 52,005 contigs that were used to create the backbone were annotated to zebrafish or human orthologs, and mapped to IPA. Duplicate contigs were collapsed to the gene-ID level using the average expression value relative to controls, resulting in 27 and 411 genes whose expression was significantly altered by 11-KT at day 1 and day 3 respectively (DESeq2, P-adj ≤ 0.1). Detailed lists of DEGs with P-adj values of <0.1 and fold change 1.5≤ or ≥-1.5 are found in Supplementary Table S3 (day 1) and Supplementary Table S4 (day 3) . There was very little overlap in DEGs at day 1 and day 3 ( Figure 4 ).
Ovarian differentially expressed genes associated with steroidogenesis and steroid action The expression of the following genes involved in steroid synthesis was altered (DESeq2, P-adj < 0.05) by 11-KT in the ovary at day 3: hsd3b2 (1.51-fold upregulated), and cytochrome P450 family 19 subfamily A member 1 (cyp19a1, 2.09-fold upregulated). In our dataset, the contig that mapped to zebrafish hsd3b2 shares 99.2% identity with rainbow trout hsd3b (E-value 0.0, accession: S72665.1) over 1363 bp. The contig that mapped to zebrafish cyp19a1 shares 99.8% identity with coho salmon gonadal aromatase (cyp19a1a, E-value 0.0, accession: HQ184096.1) partial coding sequence [54] over 687 bp. The expression of the nuclear steroid receptors androgen receptor beta (ar, 1.75-fold upregulated), and estrogen receptor beta (esr2, 2.05-fold upregulated) was significantly altered (DESeq2, P-adj < 0.05) by 11-KT. In salmonids, there are two isoforms of esr2 (estrogen receptor beta 1 and beta 2) and three contigs that mapped to either salmonid estrogen receptor beta isoforms share high sequence identity with zebrafish esr2. The expression of fshr was also increased (1.66-fold, P-adj = 0.064).
Differentially expressed genes associated with signaling and ovarian processes At day 3, the expression of apolipoprotein (apoo) and lipoprotein lipase (lpl) was increased by 11-KT 1.62-and 1.71-fold, Figure 3 . Cluster analysis of differentially expressed contigs after short-term treatment of females with 11-KT. Cluster analysis (DESeq2) of differentially expressed contigs (DESeq2, basemean > 10, P-adj < 0.05) in ovaries from females treated with 11-KT for 1 day (A, day 1) and three days (B, day 3). Expression of contigs (rows) is displayed for three independent samples (columns), with red (online) representing upregulation and green (online) representing downregulation from the mean expression value of each contig (white). Each column represents data from ovaries of a single individual.
respectively (P-adj < 0.05). The expression of transforming growth factor beta (tgf-beta) superfamily members, anti mullerian hormone (amh) (1.70-fold), and inhibin alpha (inha) (1.61-fold) was increased at day 3 (P-adj < 0.05).
Interrogation of the DEGs from the coho salmon ovary from day 3 using a published list of genes with putative androgen response elements (AREs) and/or estrogen response elements (EREs) from the testis of rainbow trout (O. mykiss) [57] , a closely related species within the same genus as coho salmon, identified eighteen genes ( Table 1) . Expression of putative ERE-containing genes annexin a11 (anx11), amh, FK506 binding protein 10 (fkb10), hsd3b2, inhibitor of DNA binding 1 (id1), interleukin 13 receptor subunit alpha 2 (il13ra2), pleckstrin homology domain containing B2 (plekhb2), and The expression of ovarian genes with putative androgen and/or estrogen response elements after treatment of females for 3 days with 11-KT. Ovarian contigs identified as altered by 11-KT were mapped to genes with putative androgen (ARE) and/or estrogen response (ERE) elements in rainbow trout [57] , a closely related species within the same genus. Data are expressed as fold change relative to controls. Comparison of genes whose expression was altered after shortterm treatment of females with 11-KT. After treatment of females with 11-KT for 1 or 3 days, 381 genes, annotated to zebrafish or human genomes, were identified as regulated by 11-KT (DESeq2, P ≤ 0.05). Only two genes were identified as being regulated by 11-KT at both day 1 and day 3: expression of dnl-type zinc finger (dnlz) was upregulated at day 1 and downregulated at day 3, and laminin subunit beta 1 (lamb1) was downregulated at day 1 and upregulated at day 3.
serpin family F member 1 (serpinf1) was upregulated (>1.3-fold, P-adj < 0.1). The expression of putative ARE-containing genes H1 histone family, member 0 (h1f0), and myosin IC (myo1c) was upregulated (>1.4-fold, P-adj < 0.01) by 11-KT. Expression of genes containing both AREs and EREs, including atpase H+ transporting V1 subunit F (atp6v1f), collagen type I alpha 1 (col1a1), collagen type VI alpha 2 (col6a2), fatty acid binding protein 2 (fabp2), G-protein signaling modulator 2 (gpsm2), hemoglobin subunit epsilon 1 (hbe1), retinol binding protein 4 (rbp4), and ubiquitin protein ligase E3 component n-recognin 7 (ubr7) was upregulated >1.3 fold (P-adj < 0.05).
Comparison of quantitative PCR and RNA-Seq data
Expression of 10 DEGs from the RNA-Seq of day 3 samples were analyzed by qPCR: amh, amine oxidase, copper containing 3 (aoc3), ar, cyp19a1, dcn, esr2, fn1, fshr, and hsd3b2 were identified by both qPCR assays and RNA-Seq as upregulated by 11-KT, while both methods indicated that protein tyrosine phosphatase, nonreceptor type 11 (ptpn11) was downregulated. The changes in expression of target genes assayed by qPCR were similar to the changes in expression derived by RNA-Seq data (Supplementary Figure S1 ) when plotted against each other (Spearman Rho R = 0.81, P < 0.01), although the slope and intercept suggests a slight bias toward estimations of larger expression differences for negative fold changes with RNA-Seq and estimations of larger expression differences for positive fold changes with qPCR.
Canonical pathways and biological functions
Treatment with 11-KT altered 6 and 32 canonical pathways (curated by IPA) at days 1 and 3, respectively ( Table 2) . Hepatic fibrosis/stellate cell activation was the top altered pathway at day 3, and the seventh at day 1, by P-value (-log 10 P = 1.58 at day 1 and 7.05 at day 3). This pathway is represented by two genes at day 1, collagen type XXIV alpha 1 (col24a1) and collagen XXVIII alpha 1 (col28a1), and 16 genes at day 3, collagen type I alpha I (col1a1), collagen type I alpha 2 (col1a2), collagen II alpha 1 (col2a1), collagen type IV alpha 2 (col4a2), collagen type IV alpha 6 (col4a6), collagen type VI alpha 1 (col6a1), collagen type VI alpha 2 (col6a2), collagen VI alpha 3 (col16a3), collagen 16 alpha 1 (col16a1), endothelin converting enzyme 1 (ece1) fibronectin 1 (fn1), laminin subunit alpha 1 (lama1), myosin heavy chain 4 (myh4), myosin light chain 9 (myl9), serpine1, tgfb2, tumor necrosis factor superfamily member 10 (tnfsf10). Additionally, other pathways altered in the ovarian follicles of 11-KT-treated females include retinoic acid receptor activation (-log 10 P = 3.40; 11 genes), aryl hydrocarbon signaling (-log 10 P = 3.23; nine genes), fatty acid beta-oxidation III (-log 10 P = 2.78; two genes), and clathrin-mediated endocytosis signaling (-log 10 P = 1.73; eight genes). The full list of canonical pathways Pathway, -log 10 P-value, number of genes represented in dataset from total genes reported in pathway.
can be found in Table 2 and genes associated with canonical pathways are shown in Supplementary Table S5 . Treatment with 11-KT was predicted to alter eight biological functions (Z-score ≥ 1.5, Figure 5A ) associated with reproductive development in the ovary at day 3, in categories of reproductive system development and function, organ morphology, tissue morphology, and organismal development. Genes associated with these biological functions are listed in Figure 5B . For the other top 10 biological function identified as altered by 11-KT, the associated genes are identified in Supplementary  Table S6 .
Discussion
Our previous study showed that 11-KT at low concentrations induces growth of primary perinucleolar stage follicles of coho salmon in vitro [32] . This study developed an in vivo model for androgen exposure to first test whether the in vitro results could be replicated in vivo, and second, to determine the androgen-induced changes in the ovarian transcriptome that precede the transformation of primary follicles into the cortical alveolus stage of secondary growth [38, 53] . Exposure to 11-KT for 20 days resulted in an early secondary follicle phenotype, and short-term exposure to 11-KT-induced rapid and widespread changes in the ovarian transcriptome with the expression of genes linked to cell, tissue, organ morphology and development, and pathways associated with extracellular matrix (ECM). This study is the first to comprehensively analyze the transcriptomic changes underlying promotion of primary follicle development by androgens in teleost fish.
11-ketotestosterone induces growth of the coho previtellogenic ovarian follicle
In vivo 11-KT treatment for 10 or 20 days resulted in plasma 11-KT concentrations within the same range that are effective in vitro [32] , and induced highly significant increases in ovarian follicle volume at both sampling points. By day 20, approximately half of the ovarian follicles contained cortical alveoli that are characteristic of the completion of primary follicle growth in Pacific salmon [38] . These changes were accompanied by a highly significant 13-fold increase in plasma E2 levels by day 20 in 11-KT-treated females. These growth effects are generally similar to those seen in vitro, where 11-KT concentrations as low as 0.03 ng/ml promoted significant increase in follicle volume, but differ in the effect of 11-KT on the appearance of cortical alveoli [32] . By day 20 of in vivo treatment, approximately half of the follicles contained peripheral cortical alveoli. In vitro, the highest concentration of 11-KT (30 ng/ml) had a minor but significant impact on the number of follicles (7%) containing cortical alveoli [32] . The difference in the effects on 11-KT on the appearance of cortical alveoli between the two models may be due to the 11-KT-induced increase in plasma E2 in vivo. In vitro, E2 did not alter size of perinucleolar follicles, but had a much greater impact than 11-KT on the presence and number of cortical alveoli even at the lowest concentration tested (0.03 ng/ml) [32] . The growth promoting effect of 11-KT in vitro is mediated via androgen receptors since the androgen receptor antagonist flutamide abolished, the growth promoting effects of 11-KT at the perinucleolar follicle stage [32] . Incubation with flutamide alone led to widespread atresia, evidence that endogenous androgens are essential survival factors. Testosterone had relatively modest growthpromoting effects in vitro on perinucleolar follicles. Blocking conversion of testosterone to E2 with an aromatase inhibitor (AI) resulted in testosterone having a similar growth-promoting potency as 11-KT on perinucleolar follicles [32] . Since the AI abolishes follicular E2 production, these results provide evidence that in vitro, none of 11-KT's actions in promoting the completion of primary follicle development are mediated by E2.
The 11-KT-induced elevation in plasma E2 levels in vivo suggests the development of an early cortical alveolus stage follicle phenotype by day 20 is likely due to a combination of early androgenic and later estrogenic effects. An androgen-induced elevation in plasma E2 was also seen at day 1 and 3 in the short-term study (discussed later), and similar effects have been reported to accompany the in vivo growth-promoting effects of 11-KT on previtellogenic ovarian follicle development of short-finned eels [58] .
The levels of plasma 11-KT decreased in the 11-KT-implanted fish from day 10 to day 20, reflecting the gradual decrease in release rate (and possibly altered clearance rates) of the implants over time, but levels were still significantly higher than control levels. For the controls, the reduction from ∼0.09 ng/ml at day 10 to ∼0.03 ng/ml at day 20 may reflect a stage-dependent decline in 11-KT levels, and/or could be due to mild chronic stress, although females behaved and fed normally during the experimental period. Plasma levels of 11-KT in females across numerous teleosts species range widely from 0.1 to 42 ng/ml [59] . In salmonids, levels in females of up to 1-18 ng/ml have been reported [60] , well within the range of concentrations that effectively promote follicle growth in vitro. Other nonaromatizable androgens, such as 5α-dihydrotestosterone may participate in increasing the follicular capacity for E2 biosynthesis [61] .
Acute effects of 11-ketotestosterone on the ovarian transcriptome
To identify the potential underlying mechanisms associated with the growth-promoting effects of 11-KT on primary follicles, we examined the effects of short-term elevation of plasma 11-KT on the ovarian transcriptome. In order to identify the early response to 11-KT before follicle growth was apparent (day 7 in vitro [32] , day 10 in the present study), females were sampled after 1 and 3 days of 11-KT treatment. Implants generated plasma 11-KT concentrations similar to those previously shown to promote follicle growth in vitro [32] and close to or within the physiological range reported for salmonids [59, 60] . The levels achieved in females implanted for 7 days (∼3.5 ng/ml) are within the same range as those achieved at day 10 in the long-term exposure study (∼1.0 ng/ml), indicating that the release profiles/levels achieved in both studies were similar.
The developing oocyte carries a vast pool of gene transcripts that are translated later in, and contribute to, oocyte development or early embryonic development. Previous studies in teleosts show that the ovarian transcriptome [62] [63] [64] [65] [66] [67] [68] [69] is dominated by abundant oocyte RNAs. To identify relatively rare transcripts in the oocyte and surrounding somatic follicle cells that are regulated by 11-KT, we adopted a strategy to maximize the coverage and the total number of unique sequence reads. The number of sequence reads has been shown to be more important than read length for increasing the accuracy of transcript abundance estimates [48, 64] . We obtained a high read count (over 805 million paired end reds) and large breadth of coverage of the coho ovary transcriptome, resulting in over 60,000 unique contigs meeting thresholds of ≥ 201 base pairs and basemean >10. We also identified numerous DEGs associated with ovarian follicle cells, such as those encoding ECM-associated proteins and proteins involved in steroidogenesis and steroid signaling, and genes that were previously reported [70] to be expressed in follicle-cell enriched mRNAs. The response of the ovarian transcriptome was very distinct between treatment days, and cluster analysis demonstrated clear and consistent transcriptional differences between control and 11-KT-treated ovaries. Only seven genes were differentially expressed at both day 1 and day 3, indicating a rapid and dynamic response to 11-KT.
Altered expression of genes associated with secondary follicle growth
Increases in expression at day 3 of transcripts encoding genes involved in steroidogenesis (fshr, hsd3b2, cyp19a1) and steroid action (ar, esr2) indicate that 11-KT potentially alters the ability of the ovarian follicle to produce and respond to sex steroids. Both hsd3b2 and cyp19a1 encode steroidogenic enzymes essential for the synthesis of E2. To our knowledge, in salmonids, only a single hsd3b gene is expressed in the gonad [71] . The expression of ovarian hsd3b in previtellogenic coho salmon [53] and hsd3b and cyp19a1a in early vitellogenic rainbow trout [72] was significantly increased in vitro by Fsh. Thus, the increase in transcript levels for these two steroidogenic enzymes we observed in response to 11-KT could be due to enhanced Fsh signaling, as suggested by the increase in fshr transcripts.
The upregulation of hsd3b and cyp19a1 transcripts after shortterm treatment with 11-KT is presumably part of the mechanism that resulted in an elevation in plasma E2 levels after both shortand long-term treatment of coho salmon with 11-KT. Elevations in plasma E2 also occur in 11-KT-treated eels [58] . Increasing E2 levels are a characteristic of the transition into early secondary follicle growth in coho salmon [38] , and are associated with increases in plasma and pituitary Fsh, and in ovarian fshr, steroidogenic acute regulatory protein (star), and hsd3b transcripts [37, 38] .
A variety of studies using coho salmon to model the transition from primary growth to secondary growth have shown increased Fsh signaling to the ovary, via increases in fshr transcripts and plasma Fsh. Fsh upregulates expression of several steroidogenic enzyme transcripts in teleost follicles in vitro [37, 38, 54, 55] . Consequently, plasma E2 levels progressively increase during early secondary growth and through vitellogenesis. The increase in plasma E2 and increased hsd3b, cyp19a1, ar, and esr2 transcripts in 11-KT-treated fish support the hypothesis that a major androgen action during previtellogenic follicle development is to prepare the follicle for production of and response to E2 at the start of secondary growth. Whether this is a direct action on the ovary, or indirectly, mediated by Fsh or other nonovarian factors remains to be established. Similarly, depending on follicle stage, the elevated plasma E2 levels in female eels treated with 11-KT was accompanied by increased ovarian fshr and cyp19a1 transcripts [58] .
Early previtellogenic secondary growth of the coho salmon ovarian follicle is characterized by the massive accumulation of cortical alveoli that eventually occupy most of the ooplasm and function in fertilization as a slow block to polyspermy [73] . No transcripts encoding cortical alveoli components were differentially expressed after short-term 11-KT treatment, but the presence of cortical alveoli after 20 days of 11-KT treatment suggests that the observed effects on cortical alveoli abundance are driven partly via increases in E2 synthesis as described above.
Lipid deposition and the accumulation of lipid droplets occur both during and after the cortical alveolus stage, depending on species [74] , followed by the onset of vitellogenesis. At day 3, 11-KT increased expression of genes involved in lipid transport/uptake (apoo, lpl), and absorption (fabp2), and decreased the expression of genes involved in fatty acid oxidation (enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase and enoyl-CoA delta isomerase 1), possibly reflecting increased storage through reduced metabolism. Genes identified by suppression subtractive hybridization as more highly expressed in midcortical alveolus stage coho salmon follicles, compared to those at LPN stage [53] , included genes involved in lipid uptake and processing (apolipoprotein e and lpl). In eels, the 11-KT-induced increase in lipid droplet abundance is accompanied by an increase in follicle transcripts encoding lipoprotein lipase [27] . Thus, lipid uptake and processing in the previtellogenic follicle may be partially regulated by androgens in two teleost models.
RNA-Seq analysis also showed that treatment with 11-KTaltered expression of a number of genes in the tgf-beta superfamily. Expression of tgfb2, inha, and amh increased at day 3. Although changes in expression of many of these genes have been described during teleost ovarian follicle development [3, 5] , information on the function of the encoded proteins in the ovary of teleosts is scarce. In previous studies, ovarian amh expression in coho salmon was considerably upregulated from the LPN stage to the midcortical alveolus stage [53] . Anti mullerian hormone is expressed in granulosa cells (GCs) of developing mammalian follicles until they reach FSH-mediated growth phases [75, 76] ; AMH may inhibit the growthpromoting effects of FSH [77] . During secondary growth of coho salmon ovarian follicles, plasma Fsh and ovarian fshr expression increase as the ovarian follicle begins to display increased steroidogenic capacity [37, 78] . The increase in expression of inha and follistatin after 11-KT exposure may reflect the ovarian follicle response to, and/or preparation for, Fsh signaling. Prior to undertaking the RNA-Seq study, we undertook a limited targeted gene approach (qPCR) on ovarian samples at day 10 and 20. Transcripts for the only differentially expressed genes in the RNA-Seq dataset that were previously measured at day 10 or 20 were hsd3b, cyp19a1, amh, inha, and fshr: transcript levels for these genes did not differ between follicles from control and 11-KT-treated females, aside from cyp19a1 [41] . This is not surprising since an early secondary follicle (early cortical alveolus stage) phenotype was apparent after 20 days of treatment with 11-KT, and volumes of follicles from 11-KT-treated females were ∼25-30% greater than controls at both day 10 and day 20. These noninformative data prompted the RNA-Seq-based examination of transcriptional changes preceding histologically observable changes in follicle size or morphology.
Effect of 11-ketotestosterone on expression of genes associated with the extracellular matrix and apoptosis Many transcripts linked to the ECM, including those encoding numerous forms of collagen and laminin, were altered by 11-KT at day 3. The ECM is integral to ovarian follicle development in vertebrates. During reproductive development, the ECM is continually reorganized to support extensive cell proliferation and differentiation [79] [80] [81] . Interactions between the ECM and follicular cells influence gene regulation, cell differentiation, and cell growth [82, 83] . The ECM regulates GC survival and proliferation in mammals [84] , and changes in the ECM composition may regulate growth factor and hormone access to the developing oocyte [81] . Some ECM-associated genes (fn1, dcn, clusterin) that are upregulated in midcortical alveolus stage follicles by Fsh in vitro [55] were also upregulated after 11-KT treatment.
Depending on species and follicle stage, androgens may inhibit [20, 85] or increase atresia in mammalian ovaries [86, 87] . Recent work shows that androgens suppress expression of proapoptotic proteins and increase fshr expression in mouse preantral granulosa cells, decreasing atresia and stimulating preantral follicle growth [22] . However, testosterone, but not DHT, promotes apoptosis of secondary Atlantic croaker ovarian follicles via a recently discovered membrane androgen receptor that shows high specificity for testosterone [88] . As in mammals (e.g., [89] [90] [91] ), E2 appears to also act as an antiapoptotic factor for teleost ovarian follicles [83, 92] . Taken together, the present results support the hypothesis that 11-KT causes extensive ECM and tissue remodeling that supports cellular proliferation, differentiation, and intraovarian communication, and may have direct or indirect (via E2) suppressive effects on apoptosis.
Canonical pathways and biological functions altered by 11-ketotestosterone
The expression of genes with putative roles in canonical pathways and specific biological functions in reproductive development was altered by 11-KT treatment at day 1 and day 3. The benefits of using transcriptome sequencing combined with RNA-Seq and pathway analysis software is that the transcriptional processes occurring at a particular time point can be identified on a global scale and altered transcriptional pathways and activated biological processes defined. The top ranked canonical pathway, at day 3 post implant affected by 11-KT was hepatic fibrosis/hepatic stellate cell activation. In the context of the ovary, this likely indicates changes in ECM composition of the follicle cell layers, which during late primary and early secondary growth, must undergo extensive remodeling to continue to provide both structural and hormonal support to developing oocytes. The genes included in this pathway with altered expression by 11-KT primarily encode ECM proteins (e.g. collagen isoforms, fn1, lama1). Retinoic acid receptor activation is the third ranked canonical pathway and clathrin-mediated endocytosis signaling is the 21st ranked canonical pathway altered by 11-KT at day 3, further implicating 11-KT in regulating biological processes in primary growth ovarian follicles. Retinals are known to be important throughout development [93] [94] [95] and are associated with lipid droplets in salmonid oocytes [96] . A number of genes involved in retinoid metabolism (including rbp4, 2.10-fold upregulated by 11-KT at day 3) were found to be expressed in rainbow trout ovaries throughout development [97] . Retinoic acid receptor alpha expression was also altered by DHT in maturing fathead minnow ovaries after 9 h of treatment in vitro [98] , in a study that also found that DHT alters cell processes relating to lipids and triglyceride metabolism. Vitellogenins synthesized in the liver in response to E2 are the principal carriers of retinoids and are sequestered into developing oocytes by receptor-mediated endocytosis. Recently, clathrins have been implicated in the receptor-mediated endocytosis of lipids and vitellogenins in a teleost [99] .
Additionally, aryl hydrocarbon receptor signaling was the third ranked canonical pathway in terms of predicted and observed regulated genes. In mammals, the aryl hydrocarbon receptor is involved in regulating the growth of preantral and antral follicles by increasing GC proliferation [100] and in regulation of E2 production [101] . Results from this study suggest that androgen-driven changes in the ovarian follicle layers provide hormonal and functional support needed for transition into secondary growth.
The IPA Pathway analysis also performs causal analyses that uses previously reported cause-effect relationships from the IPA knowledgebase and the direction of effects within a dataset to predict downstream biological consequences [102] . Using this application, a number of biological functions within the category of reproductive development are predicted to be activated in ovary as a result of 11-KT treatment, including fertility, the quantity of ovarian follicle, quantity of germ cell, and quantity of gonad. These predictions support the hypothesis that the early transcriptional events described above are driving the morphological changes observed at day 10 and day 20.
Ovarian actions of androgens in mammals: comparison with teleost models Common themes that have emerged from studies on androgenic regulation of previtellogenic ovarian follicle development of freshwater eels and coho salmon include androgen-driven increased expression of cyp19a1, increased plasma levels of E2 in vivo, and increased expression of ovarian ar, esr (coho salmon), and fshr. Some of these themes are also shared with several mammalian models in which androgens promote preantral ovarian follicle growth and survival, stimulate GC proliferation and functional differentiation, and increase sensitivity of preantral follicles to FSH [23, [103] [104] [105] ; see reviews by Prizant et al. [106] , Walters [107] , and Lebbe and Woodruff [108] . In mice, these effects are mediated by the AR: GC-specific AR knockout mice were subfertile, with ovaries that contained more preantral and atretic follicles and fewer antral follicles compared to controls [109] . A positive correlation exists in several mammalian species between AR and FSHR mRNA, and in primate [110, 111] and bovine [112] studies, androgens increased FSHR transcripts, an action that was blocked by specific AR antagonists [22, 112] . Additionally, in rats, androgens acting through the AR directly modulate FSH-induced estrogen synthesis by increasing Fshr and Cyp19a1 expression [113] . Thus, androgens synergize with FSH in the promotion of preantral follicle growth [22, 105] . Conversely, androgens are also implicated in AMH expression in hyperandrogenism [113] and a positive correlation between AMH and AR expression is observed in patients with polycystic ovary syndrome [115] . Neuron-specific androgen signaling has also been implicated as part of the mechanism underlying polycystic ovary syndrome, due to androgen excess [116] . In mice, AMH decreases the sensitivity of the ovarian follicle to FSH [77] and decreases FSH-mediated Cyp19a1 expression [117] . Thus, it is hypothesized that androgens, by increasing expression of their own receptor, amplify their effects locally and by increasing the expression of Amh, are fine-tuning the ovarian follicle's sensitivity and response to FSH. In mammals, this may protect the preantral and early antral follicle pool from early selection for maturation [107] , although it is unclear how this may translate to a semelparous species such as coho salmon.
Conclusions
This study presents a workflow in a nonmodel organism using RNASeq and pathway analysis to describe transcriptional events underlying 11-KT-induced growth of the late primary growth ovarian follicle. Previous in vitro and in vivo studies of LPN stage ovarian follicles in teleosts [25, 26, [30] [31] [32] have shown that 11-KT has strong growth-promoting effects at certain stages of ovarian development, roughly analogous to mammalian puberty. Since 11-KT is a nonaromatizable androgen, previous and current studies indicate that the effects are androgen induced and not due to the conversion of androgens to estrogens.
In early secondary growth stage coho salmon, both 11-KT and E2 promoted ovarian follicle growth in vitro [32] . In this study, E2 was increased in LPN stage coho treated with 11-KT after 3 days and cortical alveoli were present after 10 days, signifying a secondary growth stage follicle phenotype. An examination of the transcriptional changes in the ovary associated with both E2 and 11-KT at the beginning of secondary growth (ECA stage) would further define stage-specific responses to these steroids and provide a basis for mechanistic studies of the ovarian follicle stage transition.
Supplementary data
Supplementary data are available at BIOLRE online. Table S1 . Ovarian genes analyzed by qPCR, regulation of expression by 11-KT, qPCR primer sequences, and PCR product size.
Supplementary
Supplementary Table S2 . Summary statistics of the RNA-Seq pipeline showing number of paired reads, number after quality trimming, number mapped, and percent of reads mapped.
Supplementary Table S3 . Changes in expression of ovarian genes after treatment of females with 11-KT for 1 day. The table lists ovarian contigs regulated by 11-KT after 1 day, identified by DESeq2 (basemean > 10, fold change ≥ 1.5 or -1.5≤, P-adj < 0.1), showing fold change in expression relative to control values.
Supplementary Table S4 . Changes in expression of ovarian genes after treatment of females with 11-KT for 3 days. The table lists ovarian contigs regulated by 11-KT after 3 days, identified by DESeq2 (basemean > 10, fold change ≥ 1.5 or -1.5 ≤, P-adj < 0.1), showing fold change in expression relative to control values.
Supplementary Table S5 . Genes from RNA-Seq data represented in canonical pathway analyses. Top canonical pathways altered by 11-KT at day 1 and day 3; ingenuity canonical pathway, gene IDs. See Table S3 and S4 for full gene names.
Supplementary table S6. Genes associated with biological functions related to reproductive system development and function. Biological function, activation state, gene IDs. See Table S4 for full gene names.
Supplementary Figure S1 . Ovarian genes identified by RNA-Seq as regulated 11-KT, analyzed by qPCR. (A) Comparison of the relative change in expression of individual genes from ovarian samples from females treated for 3 days (day 3) with 11-KT, analyzed by qPCR and RNAseq. Genes were chosen for targeted qPCR analysis based on either the magnitude of difference from controls (aoc3, ptpn11) determined by DESeq2, or on genes known to be involved in regulation of ovarian growth/function (amh, ar, cyp19a1, dcn, esr2, fn1, hsd3b1). Values (mean ± SEM) that are statistically different from controls are marked by asterisks ( * P < 0.05; * * P < 0.01, n = 3; Student t-test). B: All qPCR and RNA-Seq expression values for the 10 genes shown in Figure S1A were plotted and their linear relationship analyzed. All values were highly correlated (Spearman correlation coefficient, R = 0.81, P < 0.01).
